Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
O Dr. V. M. Vivek Srinivas está atualmente associado ao Ensino de Microbiologia Veterinária no Pondicherry Veterinary College, na Índia. Ele concluiu seu doutorado no Indian Veterinary Research Institute (IVRI), Izatnagar, Índia. Ele é bacharel em Ciências Veterinárias e mestre em Microbiologia Veterinária pela Pondicherry Veterinary College.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating. 100 pp. Englisch. Bestandsnummer des Verkäufers 9786205528013
Anzahl: 2 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 100 pp. Englisch. Bestandsnummer des Verkäufers 9786205528013
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating. Bestandsnummer des Verkäufers 9786205528013
Anzahl: 1 verfügbar